Nateplase

N/A

Report date: 2022/01/22 15:45:00

Base Information

Drug NameNateplase
Drug Alias Name那替普酶TepaseMilyzerMMR-701
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsMyocardial Infarction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1997/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeB01AD
Related LinksKEGG